Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewGefitinib-based PROTAC® 3 is a potent EGFR PROTAC® Degrader. Comprises an EGFR inhibitor gefitinib (Iressa Cat. No. 3000) conjugated to a VHL ligand via a linker. Induces EGFR degradation (DC50 values are 11.7 nM and 22.3 nM in HCC827 (exon 19 del) and H3255 (L858R mutation) cells, respectively). Exhibits no degradation of wild-type EGFR at concentrations up to 10 μM.
PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
分子量 | 934.52 |
公式 | C47H57ClFN7O8S |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 2230821-27-7 |
PubChem ID | 135156947 |
InChI Key | NICKHWYZMNLEPJ-TZSMONEZSA-N |
Smiles | COC1=CC2=C(C(NC3=CC(Cl)=C(C=C3)F)=NC=N2)C=C1OCCCCCOCCOCCC(N[C@@H](C(C)(C)C)C(N4C[C@@H](C[C@H]4C(NCC5=CC=C(C6=C(N=CS6)C)C=C5)=O)O)=O)=O |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
DMSO | 93.45 | 100 |
以下数据基于产品分子量 934.52。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.07 mL | 5.35 mL | 10.7 mL |
5 mM | 0.21 mL | 1.07 mL | 2.14 mL |
10 mM | 0.11 mL | 0.54 mL | 1.07 mL |
50 mM | 0.02 mL | 0.11 mL | 0.21 mL |
参考文献是支持产品生物活性的出版物。
Burslem et al (2018) The advantages of targeted protein degradation over inhibition: an RTK case study. Cell Chem.Biol. 25 67 PMID: 29129716
If you know of a relevant reference for Gefitinib-based PROTAC® 3, please let us know.
关键词: Gefitinib-based PROTAC® 3, Gefitinib-based PROTAC® 3 supplier, potent, EGFR, active, degraders, degrades, Gefitinib-based, PROTAC3, inhibitors, inhibits, Iressa, epidermal, growth, factor, receptors, von, Hippel, Lindau, VHL, E3, ligases, targeted, protein, degradation, TPD, PROTACs, Iressa-based, PROTAC, 3, Receptor, Degraders, 7258, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。
目前没有 Gefitinib-based PROTAC® 3 的引用文献。 您是否知道使用了 Tocris Gefitinib-based PROTAC® 3 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review Gefitinib-based PROTAC® 3 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia